TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
SRRK

Scholar Rock Holding Corp

Healthcare · Biotechnology

46.80$ +1.4% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement SRRK
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% – – 100.0% 100.0% 100.0% 100.0% – – –
3,292.1% – – 264.6% 480.8% 576.5% 29.8% – – –
-3,192.1% – – 100.0% 100.0% -476.5% 100.0% – – –
3,292.1% – – 264.6% 480.8% 576.5% 374.9% – – –
1,085.0% – – 101.6% 183.2% 214.0% 129.9% – – –
4,377.0% – – 366.2% 664.0% 214.0% 504.8% – – –
-4,277.0% – – -266.2% -564.0% -690.5% -404.8% – – –
5.0% – – 0.0% 0.0% 10.0% 8.6% – – –
-4,276.3% – – -248.9% -561.5% -700.5% -405.2% – – –
5.0% – – -6.4% -9.7% 12.7% -8.6% – – –
-4,276.3% – – -242.5% -551.8% -700.5% -396.6% – – –
-4,125.3% – – -259.8% -554.4% -686.5% -395.8% – – –

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?